Different CD8+ T-Cell Targets in New, Established Diabetes

Autoreactive CD8+ T cells specific for preproinsulin target different epitopes

WEDNESDAY, Oct. 19 (HealthDay News) -- Autoreactive CD8+ T cells specific for preproinsulin (PPI) include central and effector memory cells and show different specificities for epitopes in patients with recent-onset and long-standing type 1 diabetes (T1D), according to a study published online Oct. 13 in Diabetes.

Sandrine Luce, from the Institut National de la Santé et de la Recherche Médicale U986 in Paris, and colleagues characterized HLA class I-restricted autoreactive CD8+ T cells specific for PPI in patients with recent-onset and long-standing T1D and healthy controls. Circulating PPI-specific CD8+ T cells were enumerated using HLA-A *02:01 tetramers complexed to PPI peptides and characterized using membrane markers and single-cell polymerase chain reaction.

The investigators found that most CD8+ T cells detected in patients with recent-onset T1D were specific for leader sequence peptides PPI6-14; and in patients with long-standing T1D, they were specific for B-chain peptide PPI33-42. Both CD8+ T-cells specificities were found to be mainly naive, central, and effector memory cells with gene-expression profile distinct from cytomegalovirus-specific CD8+ T cells. One of the healthy controls displayed Il-10 mRNA expression in PPI6 to 14-specific CD8+ T cells, which was absent in patients with diabetes.

"PPI-specific CD8+ T cells in type 1 diabetic patients include central memory and target different epitopes in new-onset versus long-standing disease," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Debunking Three Rape Myths
Journal of Forensic Nursing, October/December 2014
Expires: 12/31/2016 CE:2.5 $24.95


Drug updates and approvals: 2014 in review
The Nurse Practitioner, 13December 2014
Expires: 12/31/2016 CE:3 $27.95


Can Food Processing Enhance Cancer Protection?
Nutrition Today, September/October 2014
Expires: 10/31/2016 CE:2 $21.95


More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events